Liquid Biopsy Versus Tissue Biopsy to Determine Front Line Therapy in Metastatic Non-Small Cell Lung Cancer (NSCLC)

Authors: Raez, Luis E., Brice, Kayla, Dumais, Katerine, Lopez-Cohen, Alejandro, Wietecha, Delia, Izquierdo, Paola A., Santos, Edgardo S., Powery, Hermán W.

Source: Clinical lung cancer. 24(2):120-129

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100183343477.0x000001&indx=1&recIds=ETOCvdc_100183343477.0x000001

STARBOARD: encorafenib + binimetinib + pembrolizumab for first-line metastatic/unresectable BRAF V600-mutant melanoma

Authors: Schadendorf, Dirk, Dummer, Reinhard, Robert, Caroline, Ribas, Antoni, Sullivan, Ryan J, Panella, Timothy, McKean, Meredith, Santos, Edgardo S, Brill, Kimberli, Polli, Anna, Pietro, Alessandra di, Ascierto, Paolo A

Source: Future oncology. 18(17):2041-2051

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100191694816.0x000001&indx=1&recIds=ETOCvdc_100191694816.0x000001

Treatment Considerations for Patients With Advanced Squamous Cell Carcinoma of the Lung

Authors: Santos, Edgardo S., Rodriguez, Estelamari

Source: Clinical lung cancer. 23(6):457-466

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100169139457.0x000001&indx=1&recIds=ETOCvdc_100169139457.0x000001

Impact of PROphet Test in Changing Physicians' Therapeutic Decision-Making for Checkpoint Immunotherapy in Non–Small-Cell Lung Cancer

Authors: Gandara, David R., Subramanian, Janakiraman, Santos, Edgardo S., Brody, Yehuda, Sela, Itamar, Elon, Yehonatan, Harel, Michal, Reiner-Benaim, Anat, Lahav, Coren, McGregor, Kimberly

Source: In Clinical Lung Cancer September 2024 25(6):e252-e261

Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses

Authors: Owonikoko, Taofeek K., Niu, Huifeng, Nackaerts, Kristiaan, Csoszi, Tibor, Ostoros, Gyula, Mark, Zsuzsanna, Baik, Christina, Joy, Anil Abraham, Chouaid, Christos, Jaime, Jesus Corral, Kolek, Vitezslav, Majem, Margarita, Roubec, Jaromir, Santos, Edgardo S., Chiang, Anne C., Speranza, Giovanna, Belani, Chandra P., Chiappori, Alberto, Patel, Manish R., Czebe, Krisztina, Byers, Lauren, Bahamon, Brittany, Li, Cong, Sheldon-Waniga, Emily, Kong, Eric F., Williams, Miguel, Badola, Sunita, Shin, Hyunjin, Bedford, Lisa, Ecsedy, Jeffrey A., Bryant, Matthew, Jones, Sian, Simmons, John, Leonard, E. Jane, Ullmann, Claudio Dansky, Spigel, David R.

Source: In Journal of Thoracic Oncology February 2020 15(2):274-287

Treatment options after first-line immunotherapy in metastatic NSCLC

Authors: Santos, Edgardo S.

Source: Expert review of anticancer therapy. 20(3):221-228

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100100623337.0x000001&indx=1&recIds=ETOCvdc_100100623337.0x000001

The burden of lung cancer in Latin-America and challenges in the access to genomic profiling, immunotherapy and targeted treatments

Authors: Raez, Luis E., Cardona, Andrés F., Santos, Edgardo S., Catoe, Heath, Rolfo, Christian, Lopes, Gilberto, Barrios, Carlos, Mas, Luis A., Vallejos, Carlos, Zatarain-Barrón, Zyanya Lucia, Caglevic, Christian, Arrieta, Oscar

Source: In Lung Cancer May 2018 119:7-13

Treatment considerations for patients with advanced squamous cell carcinoma of the lung: a plain language summary

Authors: Santos, Edgardo S, Rodriguez, Estelamari

Source: Lung cancer management. 11(3)

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100192361047.0x000001&indx=1&recIds=ETOCvdc_100192361047.0x000001

Challenges in Facing the Lung Cancer Epidemic and Treating Advanced Disease in Latin America

Authors: Raez, Luis E., Santos, Edgardo S., Rolfo, Christian, Lopes, Gilberto, Barrios, Carlos, Cardona, Andres, Mas, Luis A., Arrieta, Oscar, Richardet, Eduardo, Vallejos S, Carlos, Wistuba, Ignacio, Gandara, David, Hirsch, Fred R.

Source: In Clinical Lung Cancer January 2017 18(1):e71-e79

Osimertinib for Previously Treated Patients With Advanced EGFR T790M Mutation-Positive NSCLC: Tolerability and Diagnostic Methods From an Expanded Access Program

Authors: Santos, Edgardo S., Kaplan, Barry, Kirshner, Eli, Croft, Elisabeth F., Sequist, Lecia V., Chau, MyDoanh, Munley, Jiefen, Oxnard, Geoffrey R.

Source: Oncology and therapy. 6(1):45-58

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100130967281.0x000001&indx=1&recIds=ETOCvdc_100130967281.0x000001

Making Sense of Immunotherapy in Lung Cancer: What the Pulmonologist Needs to Know?

Authors: Santos, Edgardo S., Turquie, Moises Harari, Castillero, Lilibeth, Raez, Luis E., Rolfo, Christian

Source: Current pulmonology reports. 7(2):42-48

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100129271972.0x000001&indx=1&recIds=ETOCvdc_100129271972.0x000001

BRAF mutations in non-small cell lung cancer: has finally Janus opened the door?

Authors: Caparica, Rafael, de Castro, Gilberto, Jr., Gil-Bazo, Ignacio, Caglevic, Christian, Calogero, Raffaele, Giallombardo, Marco, Santos, Edgardo S., Raez, Luis E., Rolfo, Christian

Source: In Critical Reviews in Oncology / Hematology May 2016 101:32-39

Characterization of Incidental Pathogenic Germline Findings Detected via ctDNA among Patients with Non-Small Cell Lung Cancer in a Predominantly Hispanic/Latinx Population.

Authors: Vallabhaneni, Esha, Kareff, Samuel A., Barnett, Reagan M., Drusbosky, Leylah M., Dalal, Shivani, Raez, Luis E., Santos, Edgardo S., Albrecht, Federico, Cusnir, Mike, Rodriguez, Estelamari

Source: Cancers; Mar2024, Vol. 16 Issue 6, p1150, 12p

Subject Terms: DNA analysis, GENOMICS, HISPANIC Americans, DISEASE management, RETROSPECTIVE studies, DISEASE prevalence, DESCRIPTIVE statistics, LUNG tumors, LUNG cancer, CANCER patient psychology, GENETIC mutation, TUMOR classification, SEQUENCE analysis

Geographic Terms: UNITED States

Drug Shortages in Oncology: ASCO Clinical Guidance for Alternative Treatments.

Authors: Santos, Edgardo S., Oliver, Thomas K., Lacchetti, Christina, Geisel, Rachel, Wilfong, Lalan S., Fader, Amanda N., Eng, Cathy

Source: JCO Oncology Practice; Jan2024, Vol. 20 Issue 1, p19-32, 17p

Subject Terms: INVENTORY shortages, GENERIC drug substitution, HEALTH services accessibility, ANTINEOPLASTIC agents, MEDICAL supplies, MEDICAL protocols, SUPPLY chains, DRUGS, HEALTH care teams, QUALITY control, TUMORS, DECISION making in clinical medicine, ALTERNATIVE medicine, HEALTH care rationing

Geographic Terms: UNITED States

Company/Entity: UNITED States. Food & Drug Administration, AMERICAN Society of Clinical Oncology

Novel therapeutic strategies for patients with NSCLC that do not respond to treatment with EGFR inhibitors

Authors: Rolfo, Christian, Giovannetti, Elisa, Hong, David S., Bivona, T., Raez, Luis E., Bronte, Giuseppe, Buffoni, Lucio, Reguart, Noemí, Santos, Edgardo S., Germonpre, Paul, Taron, Mìquel, Passiglia, Francesco, Van Meerbeeck, Jan P., Russo, Antonio, Peeters, Marc, Gil-Bazo, Ignacio, Pauwels, Patrick, Rosell, Rafael

Source: In Cancer Treatment Reviews September 2014 40(8):990-1004

Overcoming the resistance to Crizotinib in patients with Non-Small Cell Lung Cancer harboring EML4/ALK translocation

Authors: Perez, Cesar A., Velez, Michel, Raez, Luis E., Santos, Edgardo S.

Source: In Lung Cancer May 2014 84(2):110-115

Advanced Squamous Cell Carcinoma of the Lung: Current Treatment Approaches and the Role of Afatinib.

Authors: Santos, Edgardo S (AUTHOR), Hart, Lowell (AUTHOR)

Source: OncoTargets & Therapy. Sep2020, Vol. 13, p9305-9321. 17p.

Subject Terms: *PEMBROLIZUMAB, *SQUAMOUS cell carcinoma, *IMMUNE checkpoint inhibitors, *PEMETREXED, *COMBINATION drug therapy, *LUNGS, *PROGRESSION-free survival

Biomarkers, Prediction, and Prognosis in Non–Small-Cell Lung Cancer: A Platform for Personalized Treatment

Authors: Sudhindra, Akshay, Ochoa, Roberto, Santos, Edgardo S.

Source: In Clinical Lung Cancer November 2011 12(6):360-368

Central nervous system toxicities of chemotherapeutic agents

Authors: Peddi, Parvin F, Peddi, Srinivas, Santos, Edgardo S, Morgensztern, Daniel

Source: Expert review of anticancer therapy. 14(7):857-863

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100106840220.0x000001&indx=1&recIds=ETOCvdc_100106840220.0x000001

Immunotherapy: is a minor god yet in the pantheon of treatments for lung cancer?

Authors: Rolfo, Christian, Sortino, Giovanni, Smits, Evelien, Passiglia, Francesco, Bronte, Giuseppe, Castiglia, Marta, Russo, Antonio, Santos, Edgardo S, Janssens, Annelies, Pauwels, Patrick, Raez, Luis

Source: Expert review of anticancer therapy. 14(10):1173-1187

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100106840444.0x000001&indx=1&recIds=ETOCvdc_100106840444.0x000001